Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
1 Result for "
prpf31 mutation-associated retinal dystrophy
" in MedChemExpress (MCE) Product Catalog:
Products (1)
1 Results for "prpf31 mutation-associated retinal dystrophy" in MCE Product Catalog:
Cat. No.: HY-185930
CAS No.: 3119104-59-2
Target:
Research Areas:
Reftinirsen inapertide is a CNOT3 inhibitor. CNOT3 is a non-catalytic subunit of the CCR4-NOT complex, serving as a direct transcriptional repressor and penetrance modifier of PRPF31. Reftinirsen inapertide can be used for the research of retinal dystrophies associated with prpf31 mutations .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
